Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1978 1
1980 2
1983 1
1984 3
1985 1
1986 2
1987 2
1988 2
1989 4
1990 1
1991 2
1996 2
1997 3
1998 3
1999 1
2000 1
2001 1
2013 1
2014 2
2015 3
2016 9
2017 7
2018 11
2019 3
2020 6
2021 3
2022 4
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Results by year
Filters applied: . Clear all
Page 1
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators. Wedzicha JA, et al. Among authors: patalano f. N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Free article. Clinical Trial.
Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
Singh D, Wild JM, Saralaya D, Lawson R, Marshall H, Goldin J, Brown MS, Kostikas K, Belmore K, Fogel R, Patalano F, Drollmann A, Machineni S, Jones I, Yates D, Tillmann HC. Singh D, et al. Among authors: patalano f. Respir Res. 2022 Feb 10;23(1):26. doi: 10.1186/s12931-022-01949-3. Respir Res. 2022. PMID: 35144620 Free PMC article. Clinical Trial.
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
Chapman KR, Hurst JR, Frent SM, Larbig M, Fogel R, Guerin T, Banerji D, Patalano F, Goyal P, Pfister P, Kostikas K, Wedzicha JA. Chapman KR, et al. Among authors: patalano f. Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339. doi: 10.1164/rccm.201803-0405OC. Am J Respir Crit Care Med. 2018. PMID: 29779416 Free article. Clinical Trial.
Indacaterol/glycopyrronium: a dual bronchodilator for COPD.
Banerji D, Fogel R, Patalano F. Banerji D, et al. Among authors: patalano f. Drug Discov Today. 2018 Jan;23(1):196-203. doi: 10.1016/j.drudis.2017.10.015. Epub 2017 Oct 24. Drug Discov Today. 2018. PMID: 29079130 Review.
Patient-reported outcome measures in presbyopia: a literature review.
Sharma G, Chiva-Razavi S, Viriato D, Naujoks C, Patalano F, Bentley S, Findley A, Johnson C, Arbuckle R, Wolffsohn J. Sharma G, et al. Among authors: patalano f. BMJ Open Ophthalmol. 2020 Jul 12;5(1):e000453. doi: 10.1136/bmjophth-2020-000453. eCollection 2020. BMJ Open Ophthalmol. 2020. PMID: 32685693 Free PMC article. Review.
Addressing unmet needs in the treatment of COPD.
Patalano F, Banerji D, D'Andrea P, Fogel R, Altman P, Colthorpe P. Patalano F, et al. Eur Respir Rev. 2014 Sep;23(133):333-44. doi: 10.1183/09059180.00004014. Eur Respir Rev. 2014. PMID: 25176969 Free PMC article. Review.
Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps.
Afroz N, Gutzwiller FS, Mackay AJ, Naujoks C, Patalano F, Kostikas K. Afroz N, et al. Among authors: patalano f. Int J Chron Obstruct Pulmon Dis. 2020 Jul 23;15:1789-1800. doi: 10.2147/COPD.S235845. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32801678 Free PMC article. Review.
82 results